Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 4/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.33 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.33 |
| ▸ | ALB | P02768 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.33 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.33 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.33 |
| ▸ | HPRT1 | P00492 | 2/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.32 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.32 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10047653 | 0.87 | FGFR1 (0.74) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL13825656 | 0.82 | FGFR1 (0.75) | FGFR1LMNAPDE3ACACNA1FALB | |
| Cyclic Cidofovir SCHEMBL140858 | 0.82 | FGFR1 (1.00) | FGFR1LMNAPDE3ACACNA1FALB | |
| Cyclic Cidofovir SCHEMBL2380283 | 0.82 | FGFR1 (1.00) | FGFR1LMNAPDE3ACACNA1FALB | |
| Cyclic Cidofovir SCHEMBL14461986 | 0.82 | FGFR1 (1.00) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL27292735 | 0.82 | FGFR1 (0.69) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL14308878 | 0.81 | FGFR1 (0.71) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL13819331 | 0.81 | FGFR1 (0.70) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL14044325 | 0.78 | FGFR1 (0.68) | FGFR1HPRT1SLC22A6 | |
| SCHEMBL254710 | 0.76 | FGFR1 (0.81) | FGFR1HPRT1SLC22A6POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120165295-A1 | Compounds, Compositions and Methods for Treating Ocular Conditions | CHIMERIX, INC. (US) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165295-A1 | Compounds, Compositions and Methods for Treating Ocular Conditions | EYA3, EYA2, PDE6C | FGFR1 1923/4885LMNA 2085/4885PDE3A 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.